+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium



Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium



Journal of Clinical Microbiology 39(7): 2729-2731



Although imipenem has in vitro activity against Enterococcus faecalis and Food and Drug Administration-approved indications for treatment of infections caused by this microorganism, there are no NCCLS guidelines for susceptibility testing of imipenem versus enterococci. Therefore, the in vitro activities of penicillin, ampicillin, imipenem, and vancomycin against 201 blood isolates of E. faecalis and 24 blood isolates of Enterococcus faecium were compared. The susceptibility of isolates to penicillin or ampicillin accurately predicted the in vitro activity of imipenem. Since the susceptibility of enterococci to imipenem can be predicted by the results obtained by testing of penicillin or ampicillin, testing of imipenem by clinical laboratories probably is not necessary.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 003387310

Download citation: RISBibTeXText

PMID: 11427608

DOI: 10.1128/jcm.39.7.2729-2731.2001


Related references

Evaluation of the in vitro activities of quinupristin-dalfopristin , cefepime , linezolid , ampicillin , doxocycline , and vancomycin , alone and/or in combination against vancomycin-resistant Enterococcus faecalis and E faecium , methicillin-resistant Staphylococcus aureus , and glycopeptide intermediate-susceptible S aureus in an in vitro pharmacodynamic infection model IVPM. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 183, 2000

Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin. Memorias do Instituto Oswaldo Cruz 108(5): 590-595, 2013

In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium. International Journal of Antimicrobial Agents 34(1): 21-24, 2009

Ampicillin susceptibility can predict in vitro susceptibility of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis Isolates to amoxicillin but not to imipenem and piperacillin. Journal of Clinical Microbiology 50(11): 3729-3731, 2012

In vitro inhibition of vancomycin-susceptible and vancomycin-resistant Enterococcus faecium and E. faecalis in the presence of citrus essential oils. British Journal of Biomedical Science 66(4): 180-185, 2009

Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infection Control and Hospital Epidemiology 28(9): 1054-1059, 2007

Relationship of the incidence of vancomycin-resistant Enterococcus faecium and vancomycin-sensitive Enterococcus faecium Evidence for enhanced pathogenicity due to vancomycin-resistance. Abstracts of the General Meeting of the American Society for Microbiology 95: 111, 1995

New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains. Antimicrobial Agents and ChemoTherapy 53(5): 1952-1963, 2009

Multicenter clinical evaluation of VRESelect agar for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of Clinical Microbiology 51(8): 2758-2760, 2013

Evaluation of Spectra VRE, a new chromogenic agar medium designed to screen for vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of Clinical Microbiology 48(12): 4627-4629, 2010

Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates. Journal of Clinical Microbiology 45(5): 1556-1560, 2007

Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. Journal of Antimicrobial Chemotherapy 51(2): 323-331, 2003

Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium. Antimicrobial Agents and ChemoTherapy 36(7): 1563-1566, 1992

Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review. European Journal of Clinical Microbiology and Infectious Diseases 29(1): 107-114, 2010

Simple test of synergy between ampicillin and vancomycin for ampicillin-vancomycin resistant Enterococcus faecium. Abstracts of the General Meeting of the American Society for Microbiology 93: 14, 1993